US Patent Issued to CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) on July 15 for "Targeted ubiquitination degradation BRD4 protein compound, preparation method therefor and application thereof" (Chinese Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,358,925, issued on July 15, was assigned to CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) Co. LTD (Shijiazhuang, China).

"Targeted ubiquitination degradation BRD4 protein compound, preparation method therefor and application thereof" was invented by Chuanwu Zhao (Shijiazhuang, China), Chunhua Jiang (Shijiazhuang, China), Yan Zhang (Shijiazhuang, China), Xuejiao Zhang (Shijiazhuang, China), Jinlu Yang (Shijiazhuang, China), Jieqiong Kang (Shijiazhuang, China) and Peipei Zhao (Shijiazhuang, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "A compound represented by formula (I) or a tautomer, optical isomer, deuterated substance, oxynitride, sol...